期刊文献+

冠心病患者合并中、重度OSAS的影响因素及其对PCI术后预后的影响

An analysis of influencing factors for coronary heart disease patients complicated with moderate and severe OSAS and its innuence on prognosis after PCI
原文传递
导出
摘要 目的探讨冠心病患者合并中、重度阻塞性睡眠呼吸暂停综合征(OSAS)的影响因素及其对经皮冠状动脉介入治疗(PCI)术后预后的影响。方法行PCI的冠心病患者340例,根据睡眠呼吸暂停低通气指数(AHI)分为A组(中、重度OSAS,AHI≥15次/小时,152例)和B组(无OSAS和轻度OSAS,AHI<15次/小时,188例)。采用多因素logistic回归分析冠心病患者合并中、重度OSAS的独立危险因素。随访24个月,记录主要不良心血管事件(MACE)发生情况,Kaplan-Meier法绘制累积MACE发生曲线。结果与B组比较,A组男性、高血压和冠状动脉多支病变的比例以及BMI、颈围、腹围、hsCRP、IL-6、AHI、氧减饱和度指数较高,基线SpO_(2)、最低SpO_(2)和LVEF较低(P<0.05)。男性、冠状动脉多支病变以及BMI、hsCRP、IL-6较高是冠心病患者合并中、重度OSAS的独立危险因素,LVEF较高是其独立保护性因素(P<0.05)。A组患者累积MACE发生率高于B组(P<0.05)。结论性别、冠状动脉病变支数、BMI、hsCRP、IL-6、LVEF是影响冠心病患者合并中、重度OSAS的独立因素,合并中、重度OSAS的冠心病患者PCI术后预后更差。 Objective To analyze the influencing factors for coronary heart disease patients complicated with moderate and severe obstructive sleep apnea syndrome(OSAS)and its influence on prognosis after percutaneous coronary intervention(PCI).Methods A total of 340 patients with coronary heart disease undergoing PCI were divided into two groups of A(moderate and severe OSAS,AHI≥15 times per hour,152 cases)and B(without OSAS and mild OSAS,AHI<15 times per hour,188 cases).The independent risk factors for the patients with coronary heart disease complicated with moderate and severe OSAS were analyzed by multivariate logistic regression analysis.The major adverse cardiovascular events(MACE)were recorded after 24-month follow-up.Kaplan-Meier method was used to draw the cumulative MACE incidence curve.Results Compared with group B,group A had higher proportion of male,hypertension and coronary multi-vessel diseases,BMI,neck circumference,abdominal circumference,hsCRP,IL-6,AHI and ODI,and lower baseline SpO_(2),minimum SpO_(2) and LVEF(P<0.05).The male,multi-vessel diseases,and higher BMI,hsCRP and IL-6 were the independent risk factors for coronary heart disease patients complicated with moderate and severe OSAS,and higher LVEF was a independent protective factor(P<0.05).The cumulative incidence of MACE in group A was higher than that in group B(P<0.05).Conclusion Gender,number of lesions,BMI,hsCRP,IL-6 and LVEF are the independent influencing factors for the patients with coronary heart disease complicated with moderate and severe OSAS.The patients with coronary heart diseases complicated with moderate and severe OSAS have worse prognosis after PCI.
作者 张天磊 葛清 金晓萍 ZHANG Tianlei;GE Qing;JIN Xiaoping(Deparment of Cardiovuscular Disases,Affiliated Nanjing Hospital,Nanjing Medical University,Narjing 210006,CHINA)
出处 《江苏医药》 CAS 2023年第8期810-814,共5页 Jiangsu Medical Journal
关键词 冠心病 阻塞性睡眠呼吸暂停综合征 经皮冠状动脉介入治疗 预后 Coronary heart disease Obstructive sleep apnea syndrome Percutaneous coronary intervention Prognosis
  • 相关文献

参考文献3

二级参考文献15

  • 1Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555.
  • 2Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation, 2011, 124 :e574-651.
  • 3Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coil Cardiol, 2011,58 :e123-210.
  • 4Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation ( EuroSCORE ). Eur J Cardiothorac Surg, 1999,16:9-13.
  • 5Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009,360:961- 972.
  • 6Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coil Cardiol,2010,55:1923-1932.
  • 7Online STS fish calculator [ S/OL]. [ 2012-01-01 ]. http:// riskcalc, sts. org/STSWebRiskCalc273/de, aspx.
  • 8Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial. Lancet,2010,376 : 1233-1243.
  • 9Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Cell Cardiol,2007,50 : 1742-1751.
  • 10Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation, 2011,123:2736-2747.

共引文献430

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部